Literature DB >> 36258871

Predictors and prognosis of respiratory epithelial adenomatoid hamartoma in sinonasal cavities.

Hiroyuki Morishita1, Masayoshi Kobayashi1, Katsunori Uchida2, Kazuhiko Takeuchi1.   

Abstract

Objective: Respiratory epithelial adenomatoid hamartoma (REAH) is classified as a histopathologic diagnosis and often identified in sinus surgery for chronic rhinosinusitis (CRS). The purpose of this study was to clarify the frequency and predictors of REAH and prognosis of CRS with REAH in CRS cases.
Methods: In the first study, we histologically reviewed sinonasal polyps and mucosal tissue specimens obtained from patients who underwent endoscopic sinus surgery (ESS) for CRS to reveal how many REAH were involved in ESS cases. We compared REAH and non-REAH groups in terms of preoperative symptoms and endoscopic, imaging and blood examination findings to elucidate predictors of REAH genesis. In the second study, we compared the data 3 months after surgery such as endoscopic and imaging findings and olfactory test to evaluate prognosis of CRS with REAH.
Results: The prevalence of REAH was 15.5% of all 304 cases in the first and second studies combined. Higher polyp score in the middle meatus was an independent predictor of the presence of REAH (p = .02). Presence of REAH was significantly associated with the enlargement of olfactory cleft polyps (p < .01), increasing postoperative scores of standard olfactory tests (p = .03), and decline of ratio of improvement (p < .01) measured using T&T olfactometry. Conclusions: Higher polyp score in the middle meatus is an independent predictor of REAH. Olfactory function is difficult to recover after surgery in REAH patients because it is associated with recurrent polyps in the olfactory cleft.
© 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.

Entities:  

Keywords:  chronic rhinosinusitis; nasal polyps; nose neoplasms; olfactory disorders

Year:  2022        PMID: 36258871      PMCID: PMC9575051          DOI: 10.1002/lio2.914

Source DB:  PubMed          Journal:  Laryngoscope Investig Otolaryngol        ISSN: 2378-8038


  30 in total

1.  Can surgeons predict the olfactory outcomes after endoscopic surgery for nasal polyposis?

Authors:  Duc Trung Nguyen; Ayoub Bey; Fabien Arous; Phi-Linh Nguyen-Thi; Marylisa Felix-Ravelo; Roger Jankowski
Journal:  Laryngoscope       Date:  2015-03-05       Impact factor: 3.325

2.  Efficacy of ESS in chronic rhinosinusitis with and without nasal polyposis: a Danish cohort study.

Authors:  Henrik Lind; G Joergensen; B Lange; F Svendstrup; A D Kjeldsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-02       Impact factor: 2.503

3.  Predictors of respiratory epithelial adenomatoid hamartomas of the olfactory clefts in patients with nasal polyposis.

Authors:  Duc T Nguyen; Phi-Linh Nguyen-Thi; Guillaume Gauchotte; Fabien Arous; Jean M Vignaud; Roger Jankowski
Journal:  Laryngoscope       Date:  2014-06-13       Impact factor: 3.325

4.  Does surgery of the olfactory clefts modify the sense of smell?

Authors:  Duc Trung Nguyen; Guillaume Gauchotte; Phi-Linh Nguyen-Thi; Roger Jankowski
Journal:  Am J Rhinol Allergy       Date:  2013 Jul-Aug       Impact factor: 2.467

5.  Outcomes and imaging findings of respiratory epithelial adenomatoid hamartoma: a systematic review.

Authors:  Chetan Safi; Carol Li; Abtin Tabaee; Rohan Ramakrishna; Charles A Riley
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-18       Impact factor: 3.858

6.  The presentation and clinical significance of sinonasal respiratory epithelial adenomatoid hamartoma (REAH).

Authors:  Karen A Hawley; Sheila Pabon; Aaron P Hoschar; Raj Sindwani
Journal:  Int Forum Allergy Rhinol       Date:  2012-10-04       Impact factor: 3.858

7.  Respiratory epithelial adenomatoid hamartoma originating from nasal septum.

Authors:  Il-Ho Park; Hak Chun Lee; Heung-Man Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2011-11-29       Impact factor: 3.372

8.  Olfactory changes after endoscopic sinus surgery in patients with chronic rhinosinusitis.

Authors:  Hideki Oka; Kenzo Tsuzuki; Hironori Takebayashi; Yusuke Kojima; Takashi Daimon; Masafumi Sakagami
Journal:  Auris Nasus Larynx       Date:  2013-01-11       Impact factor: 1.863

9.  Quantification for staging sinusitis. The Staging and Therapy Group.

Authors:  V J Lund; D W Kennedy
Journal:  Ann Otol Rhinol Laryngol Suppl       Date:  1995-10

10.  Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.

Authors:  Claus Bachert; Ana R Sousa; Valerie J Lund; Glenis K Scadding; Philippe Gevaert; Shuaib Nasser; Stephen R Durham; Marjolein E Cornet; Harsha H Kariyawasam; Jane Gilbert; Daren Austin; Aoife C Maxwell; Richard P Marshall; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2017-07-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.